Gressel M G

Rockwood E J, Parrish R K, Heuer D K, Skuta G L, Hodapp E, Palmberg P F et al.

This study found that 5-FU injections after glaucoma surgery may improve success rates for high-risk patients, despite notable complications.

Heuer D K, Parrish R K, Gressel M G, Hodapp E, Desjardins D C, Skuta G L et al.

This pilot study found subconjunctival 5-FU improved surgical success rates in high-risk glaucoma filtering surgeries, suggesting its clinical utility despite side effects, but requires randomized trial confirmation.

Gressel M G, Heuer D K, Parrish R K

This study found trabeculectomy success in young patients (under 50) varied significantly by glaucoma type and age, with primary glaucoma having higher success. This helps identify high-risk patients for surgical failure.

Heuer D K, Gressel M G, Parrish R K, Anderson D R, Hodapp E, Palmberg P F

This study found trabeculectomy in aphakic eyes had a 39% success rate, significantly lower in patients under 50. This highlights the guarded prognosis for this surgery in younger aphakic patients.

Heuer D K, Parrish R K, Gressel M G, Hodapp E, Palmberg P F, Anderson D R

This pilot study found subconjunctival 5-FU after glaucoma surgery improved IOP control in high-risk eyes, suggesting a potential treatment for challenging cases, despite side effects.

Gressel M G, Parrish R K, Folberg R

This animal study showed 5-fluorouracil significantly improved glaucoma surgery success by inhibiting scarring, suggesting pharmacologic wound modulation could reduce filtering operation failures despite some toxicity.